---
title: "Vera drug scores in closely watched study in rare kidney disease"
date: Mon, 02 Jun 2025 08:51:00 -0400
source: "BioPharmaDive"
link: "https://www.biopharmadive.com/news/vera-atacicept-iga-nephropathy-origin-study-results/749512/"
---

<figure><div><img src="https://imgproxy.divecdn.com/cHs2RFOcWtoXtT_SrdEwLhKSYKW_ecNh_atlqwARHcw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNzk5NTM3MTQwXzEuanBn.webp" /></div></figure><p>Phase 3 results revealed Monday led shares to surge and should yield an approval application in IgA nephropathy, a competitive corner of drug research, later this year.&nbsp;</p>